Rallybio holders report 0% stake in amended filing
Rallybio Corp received an amended Schedule 13G filing from Balyasny Asset Management L.P. and related entities reporting that they are not beneficial owners of Rallybio’s common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Rallybio Corp received an amended Schedule 13G filing from Balyasny Asset Management L.P. and related entities reporting that they are not beneficial owners of Rallybio’s common stock. The reporting group, including BAM GP LLC, Balyasny Asset Management Holdings LP, Dames GP LLC, and Dmitry Balyasny, reports beneficial ownership of 0 shares, representing approximately 0% of the outstanding common stock, based on 5,298,137 shares outstanding as of May 8, 2026 as reported by Rallybio. The filers state they have no sole or shared voting or dispositive power over any Rallybio shares and confirm ownership of 5 percent or less of the class.
Key Figures
Key Terms
beneficial owner financial
Sole Voting Power financial
dispositive power financial
percent of class financial
Ownership of 5 percent or less of a class financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does the Schedule 13G/A filing report for Rallybio Corp (RLYB)?
What ownership percentage in Rallybio (RLYB) do the Balyasny entities report?
Do the Balyasny reporting persons have any voting power in Rallybio (RLYB)?
Who are the reporting persons in this Rallybio (RLYB) Schedule 13G/A?
What threshold statement is made about Rallybio (RLYB) ownership in Item 5?
AI-generated analysis. How Rhea-AI works. Not financial advice.